CPT Code CPT description CVX Short Description CVX Code ...

1 CPT_CodeCPT_descriptionCVX Short DescriptionCVX Codecommentlast_updatedCPT_Code_ID90281 immune globulin (Ig), human, for intramuscular useIG8614-Apr-2016990283 immune globulin (IgIV), human, for intravenous useIGIV8714-Apr-2017090287 Botulinum antitoxin, equine, any routebotulinum antitoxin2728-Feb-1717190291 Cytomegalovirus immune globulin (CMV-IgIV), human, for intravenous useCMVIG2914-Apr-2017290296 Diphtheria antitoxin, equine, any routediphtheria antitoxin1228-Feb-1717390371 Hepatitis B immune globulin (HBIg), human, for intramuscular useHBIG3014-Apr-2017490375 Rabies immune globulin (RIg), human, for intramuscular and/or subcutaneous useRIG3414-Apr-2017590376 Rabies immune globulin , heat-treated (RIg-HT)

2 , human, for intramuscular and/or subcutaneous useRIG3414-Apr-2017690378 Respiratory syncytial virus, monoclonal antibody, recombinant, for intramuscular use, 50 mg, eachRSV-MAb9314-Apr-2017790379 Respiratory syncytial virus immune globulin (RSV-IgIV), human, for intravenous useRSV-IGIV7128-Feb-1717890389 Tetanus immune globulin (TIg), human, for intramuscular useTIG1314-Apr-2017990393 Vaccinia immune globulin , human, for intramuscular usevaccinia immune globulin7914-Apr-2018090396 Varicella-zoster immune globulin , human, for intramuscular useVZIG3614-Apr-2015090470H1N1 immunization administration (intramuscular, intranasal)

3 , including counseling when performNovel Influenza-H1N1-09, all formulations12828-Feb-1729790476 Adenovirus vaccine, type 4, live, for oral useadenovirus, type 45414-Apr-2015190477 Adenovirus vaccine, type 7, live, for oral useadenovirus, type 75514-Apr-2015290581 Anthrax vaccine, for subcutaneous or intramuscular useanthrax2414-Apr-2015390585 Bacillus Calmette-Guerin vaccine (BCG) for tuberculosis, live, for percutaneous useBCG1914-Apr-2015490619 Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, tetanus toxoid carrier (MenA meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate20328-Jul-2033790620 Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), meningococcal B, OMV16314-Apr-2031490621 Meningococcal recombinant lipoprotein vaccine, serogroup B (MenB-FHbp))

4 , 2 or 3 dose schedule, f meningococcal B, recombinant16214-Apr-2031390625 Cholera vaccine, live, adult dosage, 1 dose schedule, for oral usecholera, live attenuated17414-Apr-2032790626 Tick-borne encephalitis virus vaccine, inactivated; mL dosage, for intramuscular useTick-borne encephalitis, inactivated, PF, encephalitis virus vaccine, inactivated; mL dosage, for intramuscular useTick-borne encephalitis, inactivated, PF, virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal useinfluenza, intradermal, quadrivalent, preservative free16614-Apr-2031690632 Hepatitis A vaccine (HepA), adult dosage, for intramuscular useHep A, adult5214-Apr-2015590633 Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular useHep A, ped/adol, 2 dose8314-Apr-2015690634 Hepatitis A vaccine (HepA)

5 , pediatric/adolescent dosage-3 dose schedule, for intramuscular useHep A, ped/adol, 3 dose8414-Apr-2015790636 Hepatitis A and hepatitis B vaccine (HepA-HepB), adult dosage, for intramuscular useHep A-Hep B10414-Apr-2015890644 Meningococcal conjugate vaccine, serogroups C & Y and Haemophilus influenzae type b vaccine (H Meningococcal C/Y-HIB PRP14814-Apr-2031790645 Hemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular useHib (HbOC)4728-Feb-1715990646 Hemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, intramuscular useHib (PRP-D)4628-Feb-1716090647 Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscu Hib (PRP-OMP)4914-Apr-2016190648 Haemophilus influenzae type b vaccine (Hib), PRP-T conjugate, 4 dose schedule, for intramuscular uHib (PRP-T)4814-Apr-2016290649 Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV))

6 , 3 dose schedule, for intra HPV, quadrivalent6214-Apr-2016390650 Human Papillomavirus vaccine, types 16, 18, bivalent (2vHPV), 3 dose schedule, for intramuscular uHPV, bivalent11814-Apr-2016490651 Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dos HPV916514-Apr-2031890653 Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular useinfluenza, trivalent, adjuvanted16814-Apr-2032590654 Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal useinfluenza, seasonal, intradermal, preservative free14414-Apr-2030290655 Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, mL dosage, for intramusc Influenza, seasonal, injectable, preservative free14014-Apr-2016590656 Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, mL dosage, for intramuscu Influenza, seasonal, injectable, preservative free14014-Apr-2016690657 Influenza virus vaccine, trivalent (IIV3)

7 , split virus, mL dosage, for intramuscular useInfluenza, seasonal, injectable14114-Apr-2016790658 Influenza virus vaccine, trivalent (IIV3), split virus, mL dosage, for intramuscular useInfluenza, seasonal, injectable14114-Apr-2016890659 Influenza virus vaccine, whole virus, for intramuscular or jet injection useinfluenza, whole1628-Feb-1718190660 Influenza virus vaccine, trivalent, live (LAIV3), for intranasal useinfluenza, live, intranasal11114-Apr-2018290661 Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antib Influenza, injectable, MDCK, preservative free15314-Apr-2031090662 Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased a influenza, high-dose, quadrivalent19714-Apr-2029290662 Influenza virus vaccine (IIV)

8 , split virus, preservative free, enhanced immunogenicity via increased a Influenza, high dose seasonal13514-Apr-2029290663 Influenza virus vaccine, pandemic formulation, H1N1 Novel Influenza-H1N1-09, all formulations12828-Feb-1729390664 Influenza virus vaccine, live (LAIV), pandemic formulation, for intranasal useNovel Influenza-H1N1-09, nasal12514-Apr-2029490665 Lyme disease vaccine, adult dosage, for intramuscular useLyme disease6628-Feb-1718390666 Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular Novel influenza-H1N1-09, preservative-free12614-Apr-2030090668 Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular useNovel influenza-H1N1-0912714-Apr-2029690669 Pneumococcal conjugate vaccine, 7 valent, for intramuscular usepneumococcal conjugate PCV 710028-Feb-1718490670 Pneumococcal conjugate vaccine, 13 valent (PCV13)

9 , for intramuscular usePneumococcal conjugate PCV 1313314-Apr-2018590671 Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular usePneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF21513-Sep-2134590672 Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal useinfluenza, live, intranasal, quadrivalent14914-Apr-2031990673 Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protei influenza, recombinant, injectable, preservative free15514-Apr-2031190674 Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and a Influenza, injectable, MDCK, preservative free, quadrivalent17114-Apr-2032690675 Rabies vaccine, for intramuscular userabies, unspecified formulation9014-Apr-2018690676 Rabies vaccine, for intradermal userabies, intradermal injection4014-Apr-2018790677 Pneumococcal conjugate vaccine.